Crossject annonce le vif succès de son augmentation de capital de 8 millions d’euros
04 juin 2024 13h30 HE
|
CROSSJECT
Une levée de fonds d’un montant brut de près de 8 millions d’euros Permet de poursuivre les activités de développement clinique et règlementaire de ZEPIZURE® jusqu’aux prochaines étapes de création...
Crossject announces highly successful closing of its €8 million rights offering
04 juin 2024 13h30 HE
|
CROSSJECT
Gross fundraising of approximately €8 million or 100% of the planned rights offering as proposed and announced on 30 April 2024 Allows to continue the clinical and regulatory development of ZEPIZURE®...
Crossject engage Syneos Health pour le lancement commercial du ZEPIZURE® aux États-Unis
04 janv. 2024 12h00 HE
|
CROSSJECT
Communiqué de presse Crossject engage Syneos Health pour le lancement commercial du ZEPIZURE® aux États-Unis Crossject élargit ses activités d'accès au marché dans le cadre des...
Crossject engages Syneos Health for U.S. commercial launch of ZEPIZURE®
04 janv. 2024 12h00 HE
|
CROSSJECT
Press Release Crossject engages Syneos Health for U.S. commercial launch of ZEPIZURE® Crossject expanding market access activities in preparation for filing for marketing authorization ...
Crossject reports financial results and business highlights for first half of 2023
26 sept. 2023 11h35 HE
|
CROSSJECT
Press Release Crossject reports financial results and business highlights for first half of 2023 Strong progress in bringing drugs for use in emergency situations towards the market ...
Crossject présente ses résultats financiers et faits marquants du premier semestre 2023
26 sept. 2023 11h35 HE
|
CROSSJECT
Communiqué de presse Crossject présente ses résultats financiers et faits marquants du premier semestre 2023 De solides avancées vers la mise sur le marché de médicaments dédiés aux situations...
Injectable Drug Delivery Market is anticipated to reach beyond US$ 101.2 Billion by the end of 2033, Persistence Market Research
22 mars 2023 09h35 HE
|
Persistence Market Research
New York, March 22, 2023 (GLOBE NEWSWIRE) -- The Injectable Drug Delivery Market was about US$ 41.5 Billion in 2022 to US$ 101.2 Billion by 2033, With at a CAGR of 8.4%. Injectable drug delivery...